Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
PaperCitations, authors & open-access status
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 478 citations, 2020 year and closed oa status.
478
Citations
2020
Year
closed
OA Status